STOCK TITAN
  1. Home
  2. SEEL

SEELOS THERAPEUTICS (SEEL) Stock Price, News & Analysis

SEEL OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
123 252 sessions, November 17, 2023 to November 18, 2024
Largest daily move
+59.5% close of August 16, 2024
1-year change
-99.9% closing prices, November 17, 2023 to November 18, 2024
1-month change
-61.4% closing prices, October 18, 2024 to November 18, 2024

Company Description

SEELOS THERAPEUTICS (OTC: SEEL) is classified in the pharmaceutical preparations industry and carries a market capitalization of $527.6K.

SEEL has declined 99.9% over the past year. The last closing price was $0.3900.

This page collects what Stock Titan holds for SEEL, including price data and latest news.

Stock Performance

Chart
$—
-
-
Last updated:
-99.9%
Performance 1 year
$527.6K
Market Cap
436.0K
Shares outstanding

SEELOS THERAPEUTICS (SEEL) closed at $0.3900 on November 18, 2024. Over the past 12 months, the price has lost 99.9%.

See what a $1,000 investment in SEEL would be worth today

SEEL Metrics & Rankings

Market Cap
$527.6K
View ranking
Month to date
-61.8%
View ranking
YTD
-99.8%
View ranking

Price returns through November 18, 2024. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

View All
+3.39%

Seelos Announces Second Postponement of its Annual Meeting of Stockholders

-47.76%

Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market

-22.00%

Seelos Announces Postponement of its Annual Meeting of Stockholders

+13.11%

Seelos Therapeutics Announces 1-for-16 Reverse Stock Split

stock split
+57.37%

Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to evaluate SLS-002 for treatment of PTSD

-18.80%

Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

private placement offering
-11.89%

Seelos Therapeutics Announces 1-for-8 Reverse Stock Split

stock split
-29.18%

Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis (ALS) Study with SLS-005 (IV Trehalose)

+1.90%

Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

private placement offering
+0.79%

Seelos Therapeutics Announces Receipt of Minutes from its End of Phase II Meeting with the United States Food and Drug Administration (FDA) Highlighting Modifications to the Primary and Secondary Endpoints of its Phase II Study of SLS-002

clinical trial fda approval

SEELOS THERAPEUTICS has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include stock split, private placement, offering, clinical trial, fda approval. View all SEEL news →

SEC Filings

View All

No SEC filings available for SEEL.

SEEL Company Profile & Sector Positioning

SEELOS THERAPEUTICS (SEEL) and is listed on the OTC.

Frequently Asked Questions

What is the current stock price of SEELOS THERAPEUTICS (SEEL)?

The current stock price of SEELOS THERAPEUTICS (SEEL) is $0.39 as of November 18, 2024.

What is the market cap of SEELOS THERAPEUTICS (SEEL)?

The market cap of SEELOS THERAPEUTICS (SEEL) is approximately $527.6K. Learn more about what market capitalization means .